Home » EMA Backpedaling on Protecting Trade Secret in Trials Database
EMA Backpedaling on Protecting Trade Secret in Trials Database
February 17, 2015
The European Medicines Agency appears to be backing off promises to protect industry trade secrets in its new clinical trials database, and is developing scenarios under which it would release commercially confidential information.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor